AUTL Research and Charts

AUTL - Autolus Therapeutics PLC ADR (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10)

Last 1.43	Change ⇓ -0.03 (-2.05%)	Volume 1,172,214
	Open 1.41	High 1.48	Low 1.41

8EMA (Daily) 1.41	40EMA (Daily) 1.51	50EMA (Daily) 1.52	STO (Daily) 35.548	MACD Hist (Daily) 0.019
8EMA (Weekly) 1.487	40EMA (Weekly) 1.74	50EMA (Weekly) 1.86	STO (Weekly) 24.368	MACD Hist (Weekly) -0.010


Company Profile
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises five programs: AUTO1, AUTO1/22, AUTO3, AUTO4 and AUTO6. The company operates in two geographic regions, the United Kingdom and the United States.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.